Press Release: Veterans Exploring Treatment Solutions (VETS) Applauds Texas on Passing the Largest Publicly Funded Psychedelic Research Investment in U.S. History
VETS celebrates the passage of the Texas Ibogaine Initiative—landmark legislation that allocates $100 million in public and private funding to study ibogaine-assisted therapy for PTSD, addiction, and TBI. This historic investment, driven in large part by VETS’ advocacy, positions Texas as a national leader in psychedelic research and veteran mental health care.
Press Release: Texas Launches Largest Publicly-Funded Psychedelic Research Initiative in History with $50 Million Investment in Ibogaine
Texas becomes the first state in the nation to invest in drug development trials for ibogaine, launching the largest publicly-funded psychedelic research initiative in history and offering new hope for those suffering from substance use, trauma, and brain injury.
Press Release: Veterans Exploring Treatment Solutions (VETS) Leads Legislative Day of Action in Support of AB 1103 at California State Capitol
VETS Advocacy Campaign Expands to California as Efforts for Access to Life-Changing Mental Health Treatments Continue
PRESS RELEASE: Veterans Exploring Treatment Solutions (VETS) Announces 4th Annual Torchbearer Ball to End Veteran Suicide
On November 15, 2025, the 4th Annual Torchbearer Ball returns to the iconic Hotel del Coronado. Hosted by Veterans Exploring Treatment Solutions (VETS), this black-tie gala gathers 600+ guests to honor veteran advocates, raise vital funds for psychedelic-assisted therapies, and advance the mission to end veteran suicide. This year’s Torchbearer Award will recognize filmmakers Jon Shenk and Bonni Cohen for their documentary In Waves and War, highlighting the healing journeys of Special Operations veterans.
- 8.1.2025
- News
Combat Cocktail: How America Overmedicates Veterans
A new Wall Street Journal report reveals the VA is prescribing risky drug combinations to hundreds of thousands of veterans with PTSD—despite known risks and internal warnings. The article underscores the urgent need for safer, more effective treatments like those VETS supports through research, advocacy, and access to psychedelic-assisted therapies.
- 8.1.2025
- Blog
Freedom to Heal: What It Means And Why We’re Fighting For It
At VETS, we believe that healing is a right, not a privilege. That’s what we mean by Freedom to Heal. It’s not just a phrase. It’s a promise. And it’s the driving force behind everything we do.
- 7.25.2025
- News
Ibogaine: The Fight of a Lifetime
“Ibogaine: The Fight of a Lifetime” is a Fox Nation news segment highlighting the experiences of Special Operations veterans pursuing psychedelic-assisted therapy to address traumatic brain injury and PTSD.
- 7.23.2025
- News
Advocates want NC legislature to consider rules around psychedelics for PTSD treatment
Advocates in North Carolina are urging lawmakers to support Senate Bill 568, which would create a task force to explore safe, regulated access to psychedelic-assisted therapy for PTSD—especially for veterans. While not legalizing psychedelics, the bill aims to prepare the state for future FDA approval through infrastructure planning and veteran-focused care.
- 7.16.2025
- News
RFK Jr. and other Trump officials embrace psychedelics after FDA setback
RFK Jr. and former Trump officials are backing psychedelic therapies like MDMA and ibogaine, pushing for FDA approval amid growing bipartisan interest. The article highlights veteran voices, including VETS' Marcus Capone, advocating for access despite safety concerns.
- 7.8.2025
- Blog
A New Hope for Healing: Psilocybin Clinical Trial Now Open to Veterans
Thanks to the recent passage of SB5263, Washington State is developing a robust legal framework for Washington residents over the age of 21 to access psilocybin services. With it comes a clinical trial designed specifically for U.S. veterans.